The same mechanism seems to be true when combining Nutlin-3A and radiotherapy to provide additional cellular damage and shift the cellular TP53-response towards apoptosis, already shown in TP53 wild-type esophageal squamous cell carcinoma in vitro and in vivo [65]. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.